<MedlineCitation Owner="NLM" Status="MEDLINE">
  <PMID>5281</PMID>
  <DateCreated>
    <Year>1976</Year>
    <Month>08</Month>
    <Day>03</Day>
  </DateCreated>
  <DateCompleted>
    <Year>1976</Year>
    <Month>08</Month>
    <Day>03</Day>
  </DateCompleted>
  <DateRevised>
    <Year>2003</Year>
    <Month>11</Month>
    <Day>14</Day>
  </DateRevised>
  <Article PubModel="Print">
    <Journal>
      <ISSN IssnType="Print">0014-4754</ISSN>
      <JournalIssue CitedMedium="Print">
        <Volume>32</Volume>
        <Issue>2</Issue>
        <PubDate>
          <Year>1976</Year>
          <Month>Feb</Month>
          <Day>15</Day>
        </PubDate>
      </JournalIssue>
      <Title>Experientia. </Title>
      <ISOAbbreviation>Experientia</ISOAbbreviation>
    </Journal>
    <ArticleTitle><document><s id="">Mitigation of <e id=":::diso:2,3"><w id="2">graft-versus-host</w> <w id="3">disease</w></e> in <e id=":::spe">rats</e> treated with allogeneic and xenogeneic antilymphocytic <e id=":::pgn">sera</e>.</s></document></ArticleTitle>
    <Pagination>
      <MedlinePgn>241-2</MedlinePgn>
    </Pagination>
    <Abstract>
<AbstractText>This is a very short test abstract.</AbstractText>
</Abstract>
    <AuthorList CompleteYN="Y">
      <Author ValidYN="Y">
        <LastName>Werner</LastName>
        <ForeName>C</ForeName>
        <Initials>C</Initials>
      </Author>
      <Author ValidYN="Y">
        <LastName>Ramirez</LastName>
        <ForeName>E</ForeName>
        <Initials>E</Initials>
      </Author>
      <Author ValidYN="Y">
        <LastName>Gervasoni</LastName>
        <ForeName>C</ForeName>
        <Initials>C</Initials>
      </Author>
      <Author ValidYN="Y">
        <LastName>Jeannet</LastName>
        <ForeName>M</ForeName>
        <Initials>M</Initials>
      </Author>
    </AuthorList>
    <Language>eng</Language>
    <PublicationTypeList>
      <PublicationType>Journal Article</PublicationType>
    </PublicationTypeList>
  </Article>
  <MedlineJournalInfo>
    <Country>SWITZERLAND</Country>
    <MedlineTA>Experientia</MedlineTA>
    <NlmUniqueID>0376547</NlmUniqueID>
  </MedlineJournalInfo>
  <ChemicalList>
    <Chemical>
      <RegistryNumber>0</RegistryNumber>
      <NameOfSubstance>Antilymphocyte Serum</NameOfSubstance>
    </Chemical>
    <Chemical>
      <RegistryNumber>50-18-0</RegistryNumber>
      <NameOfSubstance>Cyclophosphamide</NameOfSubstance>
    </Chemical>
  </ChemicalList>
  <CitationSubset>IM</CitationSubset>
  <MeshHeadingList>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Animals</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Antilymphocyte Serum</DescriptorName>
      <QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="Y">Bone Marrow Cells</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="Y">Bone Marrow Transplantation</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Cyclophosphamide</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Graft vs Host Reaction</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Lymph Nodes</DescriptorName>
      <QualifierName MajorTopicYN="N">immunology</QualifierName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Rats</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Transplantation, Heterologous</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Transplantation, Homologous</DescriptorName>
    </MeshHeading>
  </MeshHeadingList>
</MedlineCitation>
